Clinical Trial Update: 2019-06 TRISCEND Study [NA]

View source ↗

Summary

Update on the TRISCEND transcatheter tricuspid valve replacement trial by Edwards Lifesciences. The study is currently active but not recruiting, and results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Tricuspid Valve Regurgitation
• Valvular Heart Disease

Drugs mentioned

• TRISCEND transcatheter tricuspid valve replacement device

Snippet

Sponsor: Edwards Lifesciences | Conditions: Tricuspid Valve Regurgitation, Heart Valve Diseases | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-01-09